Combinatorial therapy for triple negative breast cancer using hyperstar polymer-based nanoparticles†
Abstract
We report the ability of a novel combinatorial therapy obtained from nanoparticles of hyperstar polymers encompassing drugs to selectively target triple negative breast cancer (TNBC) cell proliferation through STAT3 and topoisomerase-II pathways. This nano-cocktail was at least two to four fold better than the individual drugs and 6–20 times more selective than the parent drugs.